CLX
65
-3
STT
42
-17
HRB
38
-2
PCAR
42
-3
V
42
-8
ABT
57
-3
COST
56
2
DD
36
-2
ZION
53
-4
AZO
52
-4
HST
34
2
ADBE
37
6
WFC
47
-8
GLW
46
-3
YUM
30
-4
RL
66
-4
ES
28
12
CPB
22
-2
TGNA
45
-3
GILD
49
2
CLX
65
-3
STT
42
-17
HRB
38
-2
PCAR
42
-3
V
42
-8
ABT
57
-3
COST
56
2
DD
36
-2
ZION
53
-4
AZO
52
-4
HST
34
2
ADBE
37
6
WFC
47
-8
GLW
46
-3
YUM
30
-4
RL
66
-4
ES
28
12
CPB
22
-2
TGNA
45
-3
GILD
49
2
Financhill
Back

Northrop Grumman Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
45

NOC
Northrop Grumman

Last Price:
$458.64
Seasonality Move:
5.09%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
45
Northrop Grumman (NOC) is a Sell

Is Northrop Grumman a Buy, Sell or Hold?

  • The current Northrop Grumman [NOC] share price is $458.69. The Score for NOC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NOC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NOC Stock Price Chart

What is Northrop Grumman's stock price today?

  • The Northrop Grumman share price today is $458.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NOC is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

NOC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.03 Sell
Relative Strength Index (14 RSI): 36.87 Sell
Chaikin Money Flow: -168060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.89 - 479.95) Sell
Bollinger Bands (100): (481.49 - 528.79) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

NOC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 462.51 Sell
20-day SMA: 469.31 Sell
50-day SMA: 487.42 Sell
200-day SMA: 482.16 Sell
8-day EMA: 462.03 Sell
20-day EMA: 469.05 Sell
50-day EMA: 483.02 Sell
200-day EMA: 484.77 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

Northrop Grumman Earnings Growth & NOC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $1.76 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Northrop Grumman Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):